Pharmaceutical Companies
Spero Therapeutics
๐บ๐ธUnited States
- Ownership
- Public
- Established
- 2013-01-01
- Employees
- 46
- Market Cap
- $74.5M
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare...
Oncolytics Biotech
๐จ๐ฆCanada
- Ownership
- -
- Established
- -
- Employees
- 26
- Market Cap
- $74.3M
- Website
- -
Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor...
GENENTA SCIENCE SPA
๐ฎ๐นItaly
SERINA THERAPEUTICS
๐บ๐ธUnited States
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $73.8M
- Website
- -
GENELUX
๐ซ๐ทFrance
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $72.1M
- Website
- -
MediciNova
๐บ๐ธUnited States
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $71.6M
- Website
- -
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes...
Precision BioSciences
๐บ๐ธUnited States
- Ownership
- -
- Established
- -
- Employees
- 109
- Market Cap
- $70.2M
- Website
- -
Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of...
CEL-SCI
๐บ๐ธUnited States
- Ownership
- -
- Established
- -
- Employees
- 44
- Market Cap
- $68.8M
- Website
- -
CEL-SCI Corp. is a biotechnology company, which engages in the research, development and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and...
Protalix Biotherapeutics
๐ฎ๐ฑIsrael
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include...
MAIA Biotechnology
๐บ๐ธUnited States
MAIA Biotechnology, Inc. is a clinical stage biotechnology company that is engaged in the discovery, development and commercialization of therapies targeting cancer. Its product, THIO, is an investigational dual mechanism of action drug...